Sirt1 protects cultured renal medullary interstitial cells against oxidative stress.

To define the level of oxidative stress within the medulla, we performed immunohistochemical studies for oxidative stress markers on mouse kidneys. Levels of nitrosylated tyrosine and 4-hydroxynonenal were greater in the renal medulla than in the renal cortex, with expression primarily in the renal medullary interstitium (Figure ​(Figure2).2). Inner medullary interstitium appeared to have the highest levels of both oxidative stress markers (Figure ​(Figure2). 2).

Open in a separate window

Figure 2

Markers of oxidative stress in mouse kidney.

Immunohistochemistry using oxidative stress markers anti–nitrosylated tyrosine antibody (left panels) and anti–4-hydroxynonenal antibody (right panels). Panels at the bottom show high-magnification images of the renal inner medulla.

Because Sirt1 is abundantly expressed in renal medullary interstitial cells and there are high levels of oxidative stress markers in the renal medullary interstitium, we tested the role of Sirt1 in promoting cellular resistance to oxidative stress using primary cultured mouse renal medullary interstitial cells (RMICs). Downregulation of Sirt1 was achieved using a lentivirus carrying a Sirt1-selective shRNA. Sirt1 shRNA reduced endogenous Sirt1 protein expression by 85% (Figure ​(Figure3A,3A, P < 0.0001). RT-PCR also showed that Sirt1 shRNA decreased Sirt1 mRNA expression, while Sirt2 and Sirt3 mRNA expression remained unaltered (Figure ​(Figure3B).3B). Exposure of RMICs to oxidative stress (250 μM H₂O₂, 12 hours) significantly reduced cell viability, and this effect was accentuated by knockdown of Sirt1 (Figure ​(Figure3C,3C, 22% ± 4% versus 51% ± 5%, P < 0.0001). TUNEL-positive apoptosis also increased after H₂O₂ treatment (500 μM, 6 hours) and was further increased by knockdown of Sirt1 (Figure ​(Figure3E,3E, P < 0.05). H₂O₂ treatment–induced apoptosis that was further increased by knockdown of Sirt1 was also confirmed by immunoblotting for cleaved caspase-3 expression (Figure ​(Figure3G,3G, P < 0.001).

Open in a separate window

Figure 3

Sirt1 protects cultured RMICs from oxidative stress.

(A and B) Primary mouse RMICs were infected with lentivirus carrying Sirt1-selective shRNA or control virus. Expression of Sirt1, Sirt2, and Sirt3 was examined by immunoblot (A, densitometry, n = 4, *P < 0.0001) and RT-PCR (B). (C and D) Control or Sirt1 shRNA–treated RMICs were pretreated with or without Sirt1 activator resveratrol (5 μM) and challenged with H₂O₂ (250 μM) for 12 hours. Cell viability was examined by crystal violet staining (n = 6, *P < 0.0001 versus control virus–treated cells with H₂O₂; ^†P < 0.001 versus control virus–treated cells with H₂O₂ without resveratrol). (E and F) Control or Sirt1 shRNA–treated RMICs were pretreated with or without the Sirt1 activator SRT2183 (5 μM) and challenged with H₂O₂ (500 μM) for 6 hours. Cell apoptosis was examined by TUNEL assay (n = 15; *P < 0.05 versus control virus–treated cells with H₂O₂; ^†P < 0.001 versus cells with H₂O₂ without SRT2183). (G and H) Control or Sirt1 shRNA–treated RMICs were pretreated with or without the Sirt1 activator SRT2183 (5 μM) and challenged with H₂O₂ (500 μM) for 6 hours. Expression of cleaved caspase-3, a marker of cellular apoptosis, was examined by immunoblot (n = 4, densitometry; *P < 0.001 versus control virus–treated cells with H₂O₂; ^†P < 0.05 versus cells with H₂O₂ without SRT2183).

We next examined whether the Sirt1 activator resveratrol enhanced RMIC resistance to oxidative stress. Resveratrol (5 μM) significantly enhanced the ability of RMICs to tolerate oxidative stress (500 μM H₂O₂, 12 hours) (Figure ​(Figure3D,3D, 54% ± 8% versus 35% ± 3%, P < 0.001). Knockdown of Sirt1 using shRNA abolished this protective effect (Figure ​(Figure3D).3D). Treatment of RMICs with SRT2183 (5 μM), another specific and potent Sirt1 activator, also significantly reduced TUNEL-positive apoptosis after H₂O₂ treatment (Figure ​(Figure3F,3F, P < 0.001). This was further confirmed by reduced H₂O₂-induced cleaved caspase-3 level in RMICs treated with SRT2183 (Figure ​(Figure3H,3H, P < 0.05). These observations are consistent with an antioxidant role of Sirt1 in RMICs.

Sirt1 deficiency increases unilateral ureteral obstruction injury–induced apoptosis and fibrosis.

To investigate the potential protective role of Sirt1 in kidney injury, we used the unilateral ureteral obstruction (UUO) model, which has been associated with increased oxidative stress (21, 22). Although homozygous Sirt1-knockout mice exhibit severe developmental defects (23), heterozygous Sirt1-knockout mice developed normally, and their kidneys were histologically normal (Supplemental Figure 1; supplemental material available online with this article; 10.1172/JCI41563DS1). qRT-PCR (Figure ​(Figure4A,4A, P < 0.01) and immunoblot analysis (Figure ​(Figure4B,4B, P < 0.05) confirmed significantly decreased Sirt1 mRNA and protein expression in the kidney of heterozygous Sirt1-knockout (Sirt1^+/–) mice. A significant increase in Sirt1 protein expression was observed on day 3 in the obstructed kidney of both Sirt1^+/+ mice (Figure ​(Figure4C,4C, P < 0.0001) and Sirt1^+/– mice (P < 0.0001) (Figure ​(Figure4C).4C). In addition, Sirt1 was induced to a significantly lesser degree in the Sirt1^+/– than in the Sirt1^+/+ mouse kidney (Figure ​(Figure4C,4C, P < 0.001).

Open in a separate window

Figure 4

Reduced Sirt1 expression in the kidney of heterozygous Sirt1-knockout mice.

(A) Relative Sirt1 mRNA expression level in the entire kidney of wild-type (Sirt1^+/+) mice and heterozygous Sirt1-knockout (Sirt1^+/–) mice was examined by qRT-PCR (n = 4, *P < 0.01). (B) Sirt1 protein expression level in the entire kidney of Sirt1^+/+ and Sirt1^+/– mice was examined by immunoblot (n = 6, densitometry, *P < 0.05). (C) Sirt1 expression in the entire kidney of Sirt1^+/+ and Sirt1^+/– mice 3 days after UUO was examined by immunoblot (n = 4, densitometry; ^†P < 0.0001 versus contralateral kidney of Sirt1^+/+ mice; ^‡P < 0.0001 versus contralateral kidney of Sirt1^+/– mice; *P < 0.001 versus obstructed kidney of Sirt1^+/+ mice).

Renal cell apoptosis was seen predominantly in the renal medulla of mice after UUO (3 days) as assessed by TUNEL assay. TUNEL-positive apoptosis was significantly greater in the renal medulla of Sirt1^+/– mice than that of Sirt1^+/+ mice (Figure ​(Figure5A,5A, P < 0.05). Increased apoptosis in the obstructed kidney of Sirt1^+/– mice was further confirmed by higher levels of cleaved caspase-3 expression when compared with Sirt1^+/+ mice (Figure ​(Figure5B,5B, P < 0.01). Seven days after UUO, Sirius red staining, a marker of collagen, was greater in the obstructed kidney of Sirt1^+/– versus Sirt1^+/+ mice (Figure ​(Figure5C,5C, P < 0.05). This result was confirmed by higher levels of type I collagen (Col1) expression in the obstructed kidney of Sirt1^+/– mice (Figure ​(Figure5D,5D, P < 0.05). Thus Sirt1 deficiency increases renal apoptosis and fibrosis after UUO injury.

Open in a separate window

Figure 5

Sirt1 deficiency is associated with increased apoptosis and fibrosis in kidney subjected to ureteral obstruction.

(A) Representative pictures (original magnification, ×200) and quantification of TUNEL-positive apoptosis in the renal medulla of Sirt1^+/+ mice and Sirt1^+/– mice 3 days after UUO (*P < 0.05). (B) Immunoblot for expression of the apoptosis marker cleaved caspase-3 in the entire kidney of Sirt1^+/+ and Sirt1^+/– mice 3 days after UUO (n = 4, densitometry, *P < 0.01 versus Sirt1^+/+ mice). (C) Representative pictures (original magnification, ×200) and quantification of Sirius red staining on kidney sections of Sirt1^+/+ and Sirt1^+/– mice 7 days after UUO (*P < 0.05 versus obstructed kidney of Sirt1^+/+ mice). (D) Levels of Col1 protein expression in the entire kidney of Sirt1^+/+ and Sirt1^+/– mice 7 days after UUO were assessed by immunoblot (n = 5, densitometry, *P < 0.05 versus obstructed kidney of Sirt1^+/+ mice).

Sirt1 activation reduces UUO injury–induced apoptosis and fibrosis.

In contrast to Sirt1 deficiency, treatment of wild-type mice with the Sirt1 activator SRT1720 (100 mg/kg/d) significantly reduced TUNEL-positive apoptosis in the medulla of the obstructed kidney after UUO (3 days) (Figure ​(Figure6A,6A, P < 0.05). Reduced apoptosis was further confirmed by reduced cleaved caspase-3 expression in the obstructed kidney of SRT1720-treated versus vehicle-treated mice (Figure ​(Figure6B,6B, P < 0.0001). Furthermore, SRT1720 treatment significantly reduced Sirius red staining (Figure ​(Figure6C,6C, P < 0.05) and Col1 expression in the obstructed kidney after UUO (7 days) (Figure ​(Figure6D,6D, P < 0.05). Thus, increasing Sirt1 activity decreases renal apoptosis and fibrosis after UUO injury, suggesting a protective role of Sirt1 in the obstructed kidney.

Open in a separate window

Figure 6

Sirt1 activation is associated with reduced apoptosis and fibrosis in kidney subjected to ureteral obstruction.

(A) Representative images (original magnification, ×200) and quantification of TUNEL-positive apoptosis in the renal medulla of vehicle-treated or Sirt1 activator SRT1720–treated (100 mg/kg/d) wild-type mice 3 days after UUO (*P < 0.05). (B) Immunoblot for cleaved caspase-3 expression in the entire kidney of vehicle-treated or SRT1720-treated wild-type mice 3 days after UUO (n = 4, densitometry, *P < 0.0001 versus obstructed kidney of vehicle-treated mice). (C) Representative images (original magnification, ×200) and quantification of Sirius red staining on kidney sections of vehicle-treated or SRT1720-treated mice 7 days after UUO (*P < 0.05 versus obstructed kidney of vehicle-treated mice). (D) Levels of Col1 protein expression in the entire kidney of vehicle-treated or SRT1720-treated wild-type mice 7 days after UUO were assessed by immunoblot (n = 5, densitometry, *P < 0.05 versus obstructed kidney of vehicle-treated mice). V, vehicle; SRT, SRT1720.

Sirt1 regulates RMIC COX2 expression.

Sirt1 colocalizes with COX2 in RMICs, and COX2 activity is an important survival factor in RMICs (24–26). To further explore the mechanism by which Sirt1 activation protects RMICs from injury, we examined whether Sirt1 activity promoted expression of COX2 in RMICs. RMIC COX2 protein and mRNA expression was markedly increased by H₂O₂ (500 μM, 6 hours) (Figure ​(Figure7,7, A and B). H₂O₂-induced COX2 protein expression was nearly completely abolished by Sirt1 shRNA (Figure ​(Figure7A).7A). Sirt1 shRNA also dramatically reduced H₂O₂-induced COX2 mRNA expression (Figure ​(Figure7B,7B, P < 0.0001). Moreover, treatment of RMICs with the Sirt1 activator SRT2183 increased COX2 expression in a dose-dependent manner (Figure ​(Figure7C).7C). In contrast, neither H₂O₂ nor downregulation of Sirt1 altered COX1 expression (Figure ​(Figure7A),7A), and Sirt1 activator did not induce COX1 expression (data not shown), supporting a specific effect of Sirt1 on COX2 expression. Furthermore, induction of COX2 by hypertonic stress was not affected by downregulation of Sirt1 (Supplemental Figure 2), suggesting that Sirt1 is specifically involved in the COX2 response after oxidative stress.

Open in a separate window

Figure 7

Sirt1 regulates COX2 expression in cultured RMICs.

(A) Wild-type or Sirt1-knockdown cultured RMICs were challenged with H₂O₂ (500 μM) for 0, 3, or 6 hours. Expression of Sirt1, COX2, and COX1 was examined by immunoblot. (B) Wild-type or Sirt1-knockdown RMICs were challenged with H₂O₂ (500 μM) for 0 or 6 hours. COX2 mRNA expression was assessed by qRT-PCR (n = 4, *P < 0.0001 versus wild-type cells with H₂O₂). (C) RMICs were treated with the Sirt1 activator SRT2183 (0, 5, 10, 20 μM) for 8 hours, and COX2 expression was examined by immunoblot (n = 4). (D) COX2 luciferase reporter activity was measured in wild-type or Sirt1-knockdown RMICs with H₂O₂ (250 μM) for 0 or 12 hours by using the Dual Luciferase assay kit (n = 12, *P < 0.0001 versus wild-type cells with H₂O₂). (E) ChIP assay was performed on nontreated or H₂O₂-treated (500 μM, 3 hours) RMICs using anti-Sirt1 antibody and PCR primers recognizing mouse COX2 5′ sequences upstream of the transcription start site [–712, –396] or [–4,166, –3,946]. C, control: immunoprecipitation with normal rabbit IgG. Data are representative of 3 independent experiments.

Since Sirt1 activity regulates COX2 expression in vitro, we further investigated the role of Sirt1 in regulating renal COX2 expression in vivo. Abundant COX2 induction (red) was observed primarily in the renal medulla of the obstructed kidney but not the contralateral kidney (Figure ​(Figure8A).8A). Costaining confirmed COX2 expression (red) in RMICs between AQP2-stained (green) collecting ducts (Figure ​(Figure8A,8A, right). Deletion of 1 allele of Sirt1 gene significantly reduced COX2 induction in the obstructed kidney after UUO (3 days) (Figure ​(Figure8B,8B, P < 0.05). Furthermore, treatment of wild-type mice with the Sirt1 activator SRT1720 (100 mg/kg/d) markedly induced COX2 expression (red) predominantly in the RMICs between AQP2-stained (green) collecting ducts (Figure ​(Figure8C).8C). This result was further confirmed by increased renal COX2 expression in SRT1720-treated versus vehicle-treated mice as assessed by immunoblot (Figure ​(Figure8D,8D, P < 0.05). Taken together, these in vivo observations are consistent with the in vitro results and support an important role for Sirt1 in increasing COX2 expression in RMICs.

Open in a separate window

Figure 8

Sirt1 regulates COX2 expression in RMICs in vivo.

(A) Representative immunofluorescence images show COX2 induction (red) in the renal medulla of the obstructed kidney of wild-type mice 3 days after UUO. Costaining further shows induced COX2 (red) in RMICs between AQP2-positive (green) collecting ducts (right panel). (B) Immuno­blot for COX2 expression in the entire kidney of Sirt1^+/+ and Sirt1^+/– mice 3 days after UUO (n = 5, densitometry, *P < 0.05 versus obstructed kidney of Sirt1^+/+ mice). (C) Wild-type mice were treated with vehicle or Sirt1 activator SRT1720 (100 mg/kg/d) for 5 days. Immunofluorescence costaining shows that SRT1720 induces COX2 expression (red) in RMICs between AQP2-positive (green) collecting ducts. (D) COX2 expression in the entire kidney of vehicle or SRT1720-treated mice was examined by immunoblot (n = 4, densitometry, *P < 0.05 versus vehicle-treated mice).

The mechanism linking Sirt1 and COX2 was further examined. Sirt1 activity appears to regulate cultured RMIC COX2 expression at the transcriptional level, since Sirt1 shRNA significantly blunted H₂O₂-induced (250 μM, 12 hours) COX2 luciferase reporter activation (Figure ​(Figure7D,7D, P < 0.0001). To determine whether Sirt1 physically associates with the COX2 promoter, we performed a ChIP assay on H₂O₂-treated RMICs. The presence of sequence from the mouse COX2 promoter region (5′ sequence –712 to –396) in the DNAs immunoprecipitated with Sirt1 antibody was confirmed by PCR (Figure ​(Figure7E).7E). Sirt1-associated COX2 promoter sequence was detected in both nontreated cells and H₂O₂-treated cells, suggesting that Sirt1 may be associated in a transcriptional complex on the COX2 promoter region.

Compounds.

Sirt1 activators SRT1720 and SRT2183 were provided by Christoph Westphal and Jill Milne (Sirtris, a GSK company, Cambridge, Massachusetts). For 1 ml of 50 mg/ml stock dosing solution used for in vivo studies, 50 mg of SRT1720 was added into 400 μl PEG400 and vortexed to form a homogenous suspension. Tween-80 (5 μl) was added into 595 μl water and vortexed. Then Tween-80/water was added into SRT1720/PEG400 and vortexed until homogeneous. In about 5–10 minutes, the suspension became translucent-opaque. The final vehicle composition was 40% PEG400, 0.5% Tween-80, and 59.5% water. SRT1720 (100 mg/kg body weight) was given to mice by oral gavage once a day according to the company’s recommendation. For in vitro studies, SRT compounds were dissolved in DMSO. A final concentration of 0.5–10 μM SRT1720 and a final concentration of 1–20 μM SRT2183 were used.

COX2 selective inhibitor SC58236 was provided by Karen Siebert and Peter Isakson (Pfizer/Searle, New York, New York). For in vitro studies, compounds were dissolved in DMSO. A final concentration of 0.5 μM or 2.5 μM was used.

UUO.

Mice (male, 8 weeks old) were anesthetized with 50 mg/kg body weight ketamine and 100 mg/kg body weight xylazine. The left ureter was exposed via a lateral incision and ligated by 2 sutures at the level of the lower renal pole. Mice were sacrificed at day 3 or 7 after the operation. Both contralateral and obstructed kidneys were collected and assessed for gene expression, apoptosis, and fibrosis.

Immunoblot.

Protein concentration was determined using the bicinchoninic acid protein assay (Sigma-Aldrich). Fifty micrograms of proteins were loaded in each lane of a 10% SDS-PAGE minigel and run at 100 V. Proteins were transferred to a PVDF membrane at 100 V for 1 hour on ice. The membrane was washed 3 times with TBST (50 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Tween-20), incubated in blocking buffer (150 mM NaCl, 50 mM Tris, 0.05% Tween-20, and 5% Carnation nonfat dry milk, pH 7.5) for 1 hour at room temperature, and then incubated with primary antibody in blocking buffer overnight at 4°C. The primary antibodies used were: anti-Sirt1 antibody (Millipore rabbit polyclonal, 1:1,000; Sigma-Aldrich mouse monoclonal, 1:2,000), anti–cleaved caspase-3 antibody (Cell Signaling rabbit monoclonal, 1:200), anti-COX2 antibody (Cayman rabbit polyclonal, 1:1,000), anti-COX1 antibody (Cayman rabbit polyclonal, 1:1,000), anti-Col1 antibody (MD Biosciences rabbit polyclonal, 1:10,000), anti–β-actin antibody (Jackson ImmunoResearch Laboratories mouse monoclonal, 1:5,000), and anti–α-tubulin antibody (Sigma-Aldrich mouse monoclonal, 1:2,000). After 3 washes, the membrane was incubated with horseradish peroxidase–conjugated secondary antibody (Jackson Immuno­Research Laboratories, 1:5,000) for 1 hour at room temperature, followed by 3 washes with TBST. Antibody labeling was visualized by the addition of chemiluminescence reagent (PerkinElmer Life Sciences), and the membrane was exposed to Kodak XAR-5 film. Due to heterogeneous expression of Sirt1 in the kidney as well as distorted morphology of the obstructed kidney, tissue sampling (dissecting cortex from medulla) could easily have introduced artifacts into the data. For this reason, the entire kidney was homogenized, and whole kidney lysates were used for all the immunoblot studies in Figures ​Figures44–6 and ​and8. 8.

Immunohistochemistry.

Deparaffinized 5-μm sections were briefly incubated with 3% H₂O₂ and then with primary antibody for 60 minutes, rinsed with Tris-buffered saline containing 0.1% Tween-20, and incubated with a biotinylated secondary antibody for 30 minutes. After washing in PBS, sections were incubated with horseradish peroxidase–conjugated anti-biotin labeling solution (ABC Elite Kit, Vector) for 30 minutes at 22°C, followed by washing and incubation with 3,3-diaminobenzidine solution (DAB). Counterstaining was then performed before examination under a light microscope. The primary antibodies used were as follows: anti-Sirt1 antibody (Millipore rabbit polyclonal, 1:500), anti–nitrosylated tyrosine antibody, and anti–4-hydroxynonenal antibody (R&D Biosystems mouse monoclonal, 1:500).

Immunofluorescence staining.

Kidney tissues were fixed in 4% para­form­aldehyde and then incubated in 30% sucrose overnight. Cryostat sections (5 μm) were blocked with 3% normal donkey serum for 20 minutes and then incubated with primary antibody for 60 minutes at room temperature. After washing in PBS, the sections were incubated in Cy2- or Cy3-conjugated anti-IgG secondary antibody (Jackson ImmunoResearch Laboratories, 1:200) for 30 minutes and washed in PBS 5 times, and microscopy was performed with a Zeiss Axioskop and spot-cam digital camera (Diagnostic Instruments) or confocal microscope (Zeiss LSM510). The primary antibodies used for immunofluorescence studies were: anti-Sirt1 antibody (Millipore rabbit polyclonal, 1:500), anti-AQP1 antibody (Santa Cruz Biotechnology Inc. mouse monoclonal, 1:100), anti–Tamm Horsfall protein (THP) antibody (MP Biomedical goat polyclonal, 1:1,000), anti-AQP2 antibody (Santa Cruz Biotechnology Inc. goat polyclonal, 1:400), and anti-COX2 antibody (Cayman rabbit polyclonal, 1:500).

Culture of RMICs.

Mouse RMICs were prepared as described previously (9, 54). Briefly, 8 kidneys were harvested from donor C57BL6/J mice under sterile conditions, and medullary regions were excised, minced, and suspended in DMEM (Invitrogen) containing 10% (v/v) fetal bovine serum and penicillin/streptomycin. The pooled suspension containing renal medullary tissues from the donor mice was then injected intracutaneously at 3 or 4 different locations in the ventral abdominal wall of an isogeneric recipient mouse. Four days later, the recipient mouse was sacrificed, and the firm yellow nodules were removed and minced under and cells trypsinized in 0.05% trypsin-EDTA at 37°C for 15 minutes, washed, and pelleted at 230 g. The pellet was resuspended and cultured in DMEM supplemented with 10% fetal bovine serum and penicillin/streptomycin at 37°C in a 95% air/5% CO₂ incubator. The cultured mouse RMICs contained oil red O staining–positive lipid-rich droplets, which is a characteristic feature of type 1 medullary interstitial cells (55).

Sirt1 knockdown by lentivirus carrying selective Sirt1 shRNA.

HEK293T cells were cotransfected with lentiviral pLKO.1 plasmid carrying Sirt1-selective shRNA (Sigma-Aldrich MISSION shRNA library, SHCLNG-NM_019812), psPAX2 packaging plasmid, and pMD2.G envelop plasmid using FuGENE (Roche). Twelve hours later, the medium containing the transfection reagent was removed and replaced with fresh complete DMEM plus 10% FBS and penicillin/streptomycin. Twenty-four hours later, the culture medium containing lentiviral particles was harvested from HEK293T cells and transferred to a polypropylene storage tube. Virus was stored in aliquots at –80°C. Primary cultured mouse RMICs were then infected with appropriate amounts of lentiviral particles containing medium. Twenty-four hours later, virus-containing medium was removed and replaced with fresh medium. Infected mouse RMICs were cultured for 3 days, and then RT-PCR or immunoblot was performed to examine the efficiency of mRNA or protein knockdown. Controls included empty pLKO.1 plasmid or pLKO.1 plasmid containing scrambled shRNA. In addition, 2 different Sirt1-selective shRNAs from Sigma-Aldrich were used side by side in all the knockdown experiments, and they resulted in similar phenotypes.

RT-PCR.

Total RNA was extracted from cultured mouse RMICs by using TRIzol reagent (Invitrogen) and reverse transcribed using high-capacity cDNA reverse transcription kit (Applied Biosystems). The primers used for PCR were Sirt1: sense 5′-GCAACAGCATCTTGCCTGAT-3′, antisense 5′-GTGCTACTGGTCTCACTT-3′; SIRT2: sense 5′-CTTCCTGGGCATGATGAT-3′, antisense 5′-ACCCTGACTGGGCATCTAT-3′; SIRT3: sense 5′-CAGCAACCTTCAGCAGTA-3′, antisense 5′-CCGTGCATGTAGCTGTTA-3′. The PCR program used 30 cycles (94°C, 30 seconds; 58°C, 30 seconds; 72°C, 45 seconds).

qRT-PCR.

Total RNA was extracted from renal tissues or cultured RMICs using TRIzol reagent (Invitrogen). Reverse transcription was performed using a high-capacity cDNA reverse transcription kit (Applied Biosystems). qRT-PCR was performed using the Taqman gene expression assay system (Applied biosystems). The probes used were Mm01168521_m1 (mouse Sirt1), Mm00478374_m1 (mouse COX2), Mm00477214_m1 (mouse COX1), Mm00801666_g1 (mouse Col1a1), Mm00802372_m1 (mouse Col4a1). Probes for eukaryotic 18S rRNA (4319413E) were used as endogenous control. Gene expression values were calculated based on the comparative threshold cycle (Ct) method detailed in ref. 56, normalized to the expression values of 18S rRNA, and displayed as fold induction relative to control.

Crystal violet staining.

Cell viability was assessed using crystal violet staining (57–59). Culture medium was first removed, and culture plates were washed with PBS. The remaining viable attached cells were stained with 0.5% crystal violet in 50% methanol for 15 minutes at room temperature and gently rinsed with water and dried. Crystal violet in each well of 12-well plate was then re-dissolved by 500 μl of 0.1 M citrate sodium in 20% methanol, pH 5.4. Thirty minutes later, the absorbance at 570 nm was read using a spectrophotometer. For controls, cells were left untreated. Survival in the control wells with no treatment was then arbitrarily set as 100%, and the crystal violet absorbance in treated wells was compared with that in control wells to obtain the relative cell survival percentage.

TUNEL.

TUNEL assay for cultured RMICs was performed according to the manufacturer’s protocols (In Situ Cell Death Detection Kit, Fluorescein, catalog 11684795910, Roche). Vectashield mounting medium for fluorescence with DAPI (Vector) was used. Immunofluorescence microscopy was performed with a Zeiss Axioskop and spot-cam digital camera (Diagnostic Instruments). Apoptotic cell percentage was quantified by calculating the ratio of TUNEL-positive cells to DAPI-stained total nuclei on at least 15 random high-power fields (HPFs, ×400 at final magnification).

For TUNEL assay on kidney sections, 5-μm-thick sections of paraffin-embedded tissue were dewaxed and hydrated, quenched in 3% H₂O₂ for 15 minutes to remove endogenous hydroxyl peroxidase activity, and then subjected to microwave antigen retrieval and proteinase K treatment to expose DNA. Slides were incubated in a humidified chamber for 1 hour at room temperature in a reaction solution containing TdT terminal transferase (Fisher), Bio-14-dATP (Gibco, Invitrogen), and One-Phor-All buffer (supplied with TdT terminal transferase; Fisher). The reaction was terminated by two 3-minute washes in PBS, followed by 2% BSA in water for 10 minutes at room temperature, and incubated in horseradish peroxidase–conjugated anti-biotin labeling solution (ABC Elite kit, Vector) and stained with DAB. Quantification of apoptotic cells was performed by counting TUNEL-positive cells in at least 6 random HPFs in the renal medulla (including outer and inner medulla) of one kidney section.

Sirius red staining.

Collagen accumulation in kidney sections was determined by staining for Sirius red (60) and quantified by image analysis. Analysis was made without knowledge of the treatment protocol. In brief, paraffin-embedded sections were cut into 5-μm-thick sections and deparaffinized. The slides were incubated in picrosirius red solution (0.5 g Sirius red F3B [C.I. 35782, Sigma-Aldrich] in 500 ml saturated aqueous solution of picric acid) for 1 hour, and then washed in 2 changes of acidified water (5 ml acetic acid in 1 l water). After physical removal of most of the water from the slides by vigorous shaking or blotting with dam filter paper, the slides were dehydrated in 3 changes of 100% ethanol, cleared in xylene, and mounted in a resinous medium. A Zeiss Axioskop and spot-cam digital camera (Diagnostic Instruments) were used to capture 15–25 non-overlapping fields per one kidney section at a final magnification of ×200. Image analysis was performed using ImageJ with modifications of techniques described previously (61). Data are presented as the mean tubulointerstitial area occupied by collagen fibrils reactive with Sirius red compared with total area (%).

Dual luciferase reporter assay.

The 891-bp human COX2 promoter–driven Firefly luciferase reporter construct was provided by Lee-Ho Wang (Department of Hematology, University of Texas Health Science Center at Houston) (62). The COX2 reporter Firefly luciferase plasmid and a plasmid containing Renilla luciferase driven by the TK promoter (Promega) were cotransfected into primary cultured mouse RMICs using FuGENE (Roche). Dual Luciferase assay kit (Promega) was used to measure both Firefly and Renilla luciferase activity in the transfected RMICs with or without treatment. Relative luciferase activity was defined as COX2 reporter Firefly luciferase activity adjusted by Renilla luciferase activity. Data are presented as fold induction compared with control group.

ChIP assay.

ChIP assay was performed according to the manufacturer’s protocol (Millipore, ChIP Assay kit, catalog 17-295). Cultured mouse RMICs were cross-linked by 1% formaldehyde and incubated for 10 minutes at 37°C. After washing twice using ice cold PBS containing protease inhibitors, cells were scraped into conical tubes and spun down for 4 minutes at 640 g at 4°C. The cell pellet was resuspended in SDS lysis buffer and incubated for 10 minutes on ice. The lysates were sonicated on ice to shear DNA to lengths between 200 and 1,000 base pairs and then diluted 10-fold in ChIP dilution buffer with protease inhibitors. The immunoprecipitating antibody (Millipore rabbit anti-Sirt1, working concentration 5 μg/ml) was added to the supernatant fraction for overnight incubation at 4°C with rotation (for a negative control, preimmune IgG was added for immunoprecipitation). Then salmon sperm DNA/protein A agarose slurry (50 μl into 2 ml supernatant) was added for 1-hour incubation at 4°C with rotation. The agarose was pelleted by gentle centrifugation (100 g at 4°C, ~1 minute). The supernatant containing unbound, nonspecific DNA was removed. The protein A agarose complex was washed for 3–5 minutes on a rotating platform with the washing buffers supplied with the kit. The precipitated complex was eluted from the antibody by adding freshly prepared elution buffer (1% SDS, 0.1 M NaHCO₃), vortexed briefly, and incubated at room temperature for 15 minutes. The agarose was then spun down, and the supernatant fraction (eluate) was transferred to another tube and elution repeated. Eluates were combined and protein-DNA crosslinks were reversed by adding 5 M NaCl (20 μl into 500 μl) and heating at 65°C for 4 hours. The reverse-crosslinked eluates were further treated with proteinase K, and DNA was recovered by phenol/chloroform extraction and ethanol precipitation. Pellets were washed with 70% ethanol and air dried. Pellets were then resuspended in an appropriate buffer for PCR. The primers used were as follows: [–712, –396] region, sense 5′-CAGCAGGGGGAAAATACCTT-3′, antisense 5′-CGGGATCTAAGGTCCTAACT-3′; [–4,166, –3,946] region, sense 5′-GGACTGGCTAGAGACATTGA-3′, antisense 5′-AGCAGGGAACACATGGATGA-3′. The PCR program used 30 cycles (94°C, 30 seconds; 60°C, 1 minute; 72°C, 1 minute).

This work is supported by NIDDK grants DK071876 and DK074116 (to C.-M. Hao) and DK44757 and DK56942 (A.B. Fogo). R. Zent is recipient of NIH grants DK075594 and DK65123, an American Heart Association established investigator award, and a merit award from the Department of Veterans Affairs. L. You is supported by an International Society of Nephrology Fellowship grant.